Sunrise Health Sytems Hospitals Earn 'Top Performer on Key

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Sunrise Health Sytems Hospitals Earn 'Top Performer on Key Quality Measures(R)' Recognition from The Joint Commission

LAS VEGAS, Nov. 17, 2015 (GLOBE NEWSWIRE) -- The Sunrise Health System, which is comprised of MountainView, Southern Hills and Sunrise hospitals, announced today that each has been recognized as a 2014 Top Performer on Key Quality Measures® by The Joint Commission, the leading accreditor of health care organizations in the United States.

MountainView, Southern Hills and Sunrise hospitals were recognized as part of The Joint Commission's 2015 annual report "America's Hospitals: Improving Quality and Safety," for attaining and sustaining excellence in performance on its accountability measures during 2014 for heart attack, heart failure, pneumonia and surgical care.

MountainView, Southern Hills and Sunrise are three of only 1,043 hospitals out of more than 3,300 eligible hospitals in the United States to achieve the 2014 Top Performer distinction.

The Top Performer program recognizes hospitals for improving performance on evidence-based interventions that increase the chances of healthy outcomes for patients with certain conditions. The performance measures included in the recognition program including heart attack, heart failure, pneumonia, surgical care, children's asthma, inpatient psychiatric services, stroke, venous thromboembolism, perinatal care, immunization, tobacco treatment and substance use.

"The Sunrise Health Hospitals take great pride in achieving this distinction from The Joint Commission," said Todd Sklamberg, CEO, Sunrise and Sunrise Children's Hospital. "At Sunrise, our primary focus is always on the patient and providing high-quality care while enhancing the patient experience. These key quality measures have been a team effort involving every aspect of our facility."

"At MountainView, Southern Hills and Sunrise hospitals, we have made it a top priority to address patient safety and quality health care by improving upon our evidence-based care processes," said Adam Rudd, CEO at Southern Hills Hospital. "Southern Hills is proud to be named a Top Performer for five consecutive years. Along with our sister facilities, we want to thank our entire hospital staff for its knowledge, teamwork and dedication to continuous improvement and patient care."

To be a 2014 Top Performer, hospitals had to meet three performance criteria based on 2014 accountability measure data, including:

  • Achieve cumulative performance of 95 percent or above across all reported accountability measures;
  • Achieve performance of 95 percent or above on each and every reported accountability measure with at least 30 denominator cases; and
  • Have at least one core measure set that had a composite rate of 95 percent or above, and within that measure set, achieve a performance rate of 95 percent or above on all applicable individual accountability measures.

"We understand what matters most to patients at MountainView Hospital is the quality and safety of the care they receive," said Chris Mowan, CEO, MountainView Hospital. "MountainView is proud to be named a Top Performer for four years as it recognizes the knowledge, teamwork and dedication of our entire hospital staff."

For more information about the Top Performer program, visit www.jointcommission.org/accreditation/top_performers.aspx .

About Sunrise Health:

Sunrise Health is the most technologically advanced hospital network in the Southwest. Committed to providing the finest healthcare, Sunrise Health includes Sunrise Hospital & Medical Center, MountainView Hospital, Southern Hills Hospital and Medical Center and Sunrise Children's Hospital, as well as outpatient diagnostic, imaging and surgical centers. Specialty services include a suite of the latest diagnostic and surgical technologies, advanced cardiovascular services, comprehensive neurological services, a designated Comprehensive Cancer Center, The Nevada Neurosciences Institute, The Breast Center at Sunrise, MountainView Cardiovascular & Thoracic Surgery Associates, the state's most comprehensive Children's Hospital and women's healthcare services and Las Vegas' first network of certified Stroke Centers and Accredited Chest Pain Centers. For more information on Sunrise Health, visit SunriseHealthInfo.com.

Jennifer McDonnell Vice President, Marketing & Communications MountainView Hospital 702.562.5633 office

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 31

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of Canada Considers Interest Rate Cuts Amid Growth Concerns

Updated Category News Views 91

Bank of Canada Considers Possible Rate Cuts Recent discussions reported by the Financial Times reveal that Governor Tiff Macklem of the Bank of Canada has started exploring the possibility of increasing the pace at which interest rates could be cut. This potential shift highlights the Bank's response to growing concerns about the Canadian economy's current dynamics....

Continue Reading
Photonics Market Poised for Massive Growth by 2030

Updated Category News Views 151

Understanding the Photonics Market Growth The photonics industry is on an impressive trajectory, with projections indicating it will grow significantly over the coming years. Experts foresee the market expanding from approximately USD 1,093.96 billion to an astounding USD 1,481.80 billion by 2030, reflecting a compound annual growth rate (CAGR) of around 6.3%. This rapid...

Continue Reading
Brookfield Infrastructure Plans Redemption of Preferred Units

Updated Category News Views 154

Brookfield Infrastructure Announces Series 3 Redemption Plan BROOKFIELD, News - Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) has announced its intention to redeem all outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”). This strategic decision aims to enhance their portfolio's financial...

Continue Reading
How a $1000 Investment in Enphase Energy Grew to $3200

Updated Category News Views 147

Transforming $1000 into $3200 with Enphase Energy Investing can be a journey filled with uncertainties, but the story of Enphase Energy (NASDAQ: ENPH) reveals a powerful lesson in the potential of financial growth. Over the past five years, Enphase Energy has impressively outperformed many market benchmarks, achieving a remarkable annualized return of 26.49%. At present,...

Continue Reading
Investors Should Pay Attention: Rocket Pharmaceuticals Lawsuit Update

Updated Category News Views 191

The Class Action Lawsuit Against Rocket Pharmaceuticals Recently, investors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) have been advised to participate in a class action lawsuit for potential securities fraud. This lawsuit arises from significant concerns over the company's disclosure practices and the impact of leadership decisions on stock performance. If you are an...

Continue Reading